Product
PTR-01
1 clinical trial
1 indication
Clinical trial
A Phase 2b Open-Label Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01 in Study PTR-01-002Status: Completed, Estimated PCD: 2022-06-20